Liver and kidney function of patients undergoing to a controlled ovarian hyperstimulation (COH) during an in vitro fertilization (IVF) cycle

被引：0
|
作者：
Romito, Ilaria [1 ]
Gulino, Ferdinando A. [1 ]
Tuscano, Attilio [1 ]
Di Gregorio, L. M. [1 ]
Di Stefano, A. [1 ]
Leanza, Gianluca [1 ]
Leanza, Vito [1 ]
Palumbo, Marco A. [1 ]
机构：
[1] Univ Catania, S Bambino Hosp, Div Obstet & Gynecol, Ctr Physiopathol Reprod,Dept Surg, I-95124 Catania, Italy
来源：
GYNECOLOGICAL ENDOCRINOLOGY | 2016年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P193
引用
收藏
页码：146 / 146
页数：1
相关论文
共 50 条
  • [31] Highly purified (HP) Repronex® SC and HP-Repronex® IM are as effective as Repronex® SC in a prospective, randomized clinical trial evaluating controlled ovarian hyperstimulation (COH) in patients undergoing in-vitro fertilization (IVF).
    Marshall, DC
    Webster, BW
    Najmabadi, S
    Dickey, RP
    Crain, JL
    Somkuti, SG
    Magarelli, P
    Elkind-Hirsch, K
    Steinkampf, MJ
    [J]. FERTILITY AND STERILITY, 2002, 77 (04) : S15 - S15
  • [32] Comparison of GnRH agonist and antagonist protocols for controlled ovarian hyperstimulation (COH) in poor response IVF patients.
    Winston, NJ
    Puccini, M
    Nelson, L
    Scoccia, H
    [J]. FERTILITY AND STERILITY, 2004, 82 : S123 - S124
  • [33] Does physicians' experience influence in vitro fertilization success in patients undergoing controlled ovarian hyperstimulation with GnRH antagonists?
    Orvieto, Raoul
    Rabinson, Jacob
    Meltcer, Simion
    Gemer, Ofer
    Anteby, Eyal Y.
    Zohav, Efraim
    [J]. FERTILITY AND STERILITY, 2008, 89 (03) : 736 - 737
  • [34] What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?
    Orvieto, Raoul
    Meltcer, Simion
    Homburg, Roy
    Nahum, Ravit
    Rabinson, Jacob
    Ashkenazi, Jacob
    [J]. FERTILITY AND STERILITY, 2009, 91 (04) : 1466 - 1468
  • [35] Prediction of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization
    Kahnberg, Annika
    Enskog, Anders
    Brannstrom, Mats
    Lundin, Kersti
    Bergh, Christina
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (12) : 1373 - 1381
  • [36] Poor responders to controlled ovarian hyperstimulation for in vitro fertilisation (IVF)
    Kamble, Lata
    Gudi, Anil
    Shah, Amit
    Homburg, Roy
    [J]. HUMAN FERTILITY, 2011, 14 (04) : 230 - 245
  • [37] Unilateral Ovarian Torsion in Triplex Pregnancy after Ovarian Hyperstimulation and in Vitro Fertilization (IVF)
    Da Costa, Andre Luiz Eigenheer
    Sene, Ingridi Sousa
    [J]. JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2005, 9 (04): : 27 - 32
  • [38] THE EFFECTS OF CABERGOLINE ON OVARIAN HYPERSTIMULATION SYNDROME (OHSS) AND PREGNANCY OUTCOMES ON IN VITRO FERTILIZATION (IVF) PATIENTS
    Gualtieri, M.
    Hoffman, D.
    Barrionuevo, M.
    Christie, D.
    Mouhayar, Y.
    Ory, S. J.
    [J]. FERTILITY AND STERILITY, 2011, 96 (03) : S259 - S260
  • [39] Thyroid function modifications in women undergoing controlled ovarian hyperstimulation for in vitro fertilization: a systematic review and meta-analysis
    Busnelli, Andrea
    Cirillo, Federico
    Levi-Setti, Paolo Emanuele
    [J]. FERTILITY AND STERILITY, 2021, 116 (01) : 218 - 231
  • [40] The usage of Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, X.
    Fu, Y.
    [J]. HUMAN REPRODUCTION, 2016, 31 : 420 - 421
12345